| 97.49 Data as of Jun 06 |  +2.89 / +3.05%Today’s Change | 67.64 Today|||52-Week Range 114.95 | +13.10% Year-to-Date |
| 'Mad Money' Lightning Round: Amgen's Not a Fave Jun 06 / TheStreet.com | Stock Market News for June 3, 2013 - Market News Jun 03 / Zacks.com |
| Cramer's 'Mad Money' Recap: Profit While You Can Jun 05 / TheStreet.com | Top Trade Ideas For The Week Of June 3, 2013: Bonus Idea Jun 03 / StockTwits |
| CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward Jun 04 / TheStreet.com | Amgen-Astellas Collaborate - Analyst Blog May 29 / Zacks.com |
| Amgen Inc (AMGN): Today's Featured Drugs Laggard Jun 03 / TheStreet.com | Supreme Court: US genes patent decision may depend on strands in Myriad argument May 28 / FT.com |
| CHMP Positive on Teva's Lonquex - Analyst Blog Jun 03 / Zacks.com | Biotech: it's back May 27 / FT.com |
| Previous close | 94.60 |
| Today’s open | 95.01 |
| Day’s range | -- - -- |
| Volume | 4,670,757 |
| Average volume (3 months) | 4,084,982 |
| Market cap | $70.9B |
| Dividend yield | 1.93% |
| Earnings growth (last year) | +36.63% |
| Earnings growth (this year) | +11.74% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +9.57% |
| P/E ratio | 16.5 |
| Price/Sales | 3.89 |
| Price/Book | 3.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences Inc | +1.23 | +2.45% |
| BIIBBiogen Idec Inc | +7.09 | +3.31% |
| BAXBaxter International... | +0.69 | +1.00% |
| LIFELife Technologies Co... | +0.23 | +0.31% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.74 |
| Annual revenue (last year) | $17.2B |
| Annual profit (last year) | $4.3B |
| Net profit margin | 25.27% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Robert A. Bradway, MBA |
Chief Financial Officer & Executive Vice President Jonathan M. Peacock, CA |
Corporate headquarters Thousand Oaks, California |
.
